
NIH uncertainty amid federal restrictions, leadership changes; a brain mechanism that suppresses fear; hospital ventilation may spread viruses – Morning Medical Update
Key Takeaways
- NIH faces disruptions from federal restrictions and leadership changes, raising concerns about impacts on medical research and critical disease research setbacks.
- UCL researchers identified the ventrolateral geniculate nucleus as key in fear suppression, challenging traditional views and offering potential anxiety disorder treatments.
The top news stories in medicine today.
The National Institutes of Health (NIH) is grappling with disruptions under the new Trump administration. A communications blackout, halted recruitment of patients for clinical trials and a hiring freeze have created widespread confusion, anxiety and fear among NIH scientists and doctors. While some restrictions are easing, concerns remain over the potential impact on medical research. The prospect of Robert F. Kennedy Jr. leading the U.S. Department of Health and Human Services (HHS) and Jay Bhattacharya, MD, PhD, directing the NIH has intensified fears within the scientific community, with experts warning of potential setbacks in critical disease research. Read more from
Researchers at
The process is regulated by endocannabinoids, which decrease inhibitory signals to vLGN neurons, allowing the brain to adapt fear responses. Researchers aim to explore these findings in humans, paving the way for targeted therapeutic interventions.
Additional new research from UCL and UCL Hospitals suggests that hospital ventilation systems and air purifiers may unintentionally spread viral particles, increasing the risk of infections. Published in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.



















